Omega-3-acid ethyl esters

被引：0
|
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2010年 / 33卷 / 06期
关键词：
CARDIOVASCULAR-DISEASE; FATTY-ACIDS; OMEGA-3-FATTY-ACIDS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：196 / 197
页数：2
相关论文
共 50 条
  • [1] Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia
    Tatsuno, Ichiro
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (11) : 1261 - 1268
  • [2] Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides
    Kedia, Anurag W.
    Lynch, Erin
    POSTGRADUATE MEDICINE, 2015, 127 (08) : 869 - 873
  • [3] Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic β-cell response in subjects with primary hypertriglyceridemia
    Maki, Kevin C.
    Lawless, Andrea L.
    Kelley, Kathleen M.
    Dicklin, Mary R.
    Schild, Arianne L.
    Rains, Tia M.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2011, 85 (3-4): : 143 - 148
  • [4] Combination therapy with prescription omega-3-acid ethyl esters and statin improves non-HDL-C more effectively than statin alone
    Reiner, Zeljko
    CLINICAL LIPIDOLOGY, 2010, 5 (03) : 325 - 328
  • [5] Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients
    Bays, Harold E.
    Maki, Kevin C.
    McKenney, James
    Snipes, Rose
    Meadowcroft, Amy
    Schroyer, Rosemary
    Doyle, Ralph T.
    Stein, Evan
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (04) : 907 - 915
  • [6] Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer
    Ford, Nikki A.
    Rossi, Emily L.
    Barnett, Kelsey
    Yang, Peiying
    Bowers, Laura W.
    Hidaka, Brandon H.
    Kimler, Bruce F.
    Carlson, Susan E.
    Shureiqi, Imad
    deGraffenried, Linda A.
    Fabian, Carol J.
    Hursting, Stephen D.
    CANCER PREVENTION RESEARCH, 2015, 8 (09) : 796 - 806
  • [7] Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects
    Khwarg, Juyoung
    Lee, Soyoung
    Jang, In-Jin
    Kang, Won-Ho
    Lee, Hye Jung
    Kim, Kyu Yeon
    Jeong, Ki-Sun
    Won, Chongho
    Choi, Youn Woong
    Ha, Dae Chul
    Jung, Raehoon
    Han, Min-Gu
    Jung, Won Tae
    Nam, Kyu-Yeol
    Kim, Yeseul
    Yu, Kyung-Sang
    Oh, Jaeseong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 395 - 406
  • [8] Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia
    Maki, Kevin C.
    Bays, Harold E.
    Dicklin, Mary R.
    Johnson, Susan L.
    Shabbout, Mayadah
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (06) : 483 - 492
  • [9] Relative Bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat Dosing in Healthy Volunteers
    Hussey, Elizabeth K.
    Portelli, Samm
    Fossler, Michael J.
    Gao, Feng
    Harris, William S.
    Blum, Robert A.
    Lates, Christian D.
    Gould, Elizabeth
    Abu-Baker, Omar
    Johnson, Susan
    Reddy, Karunakar K.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (01): : 14 - 23
  • [10] Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia
    Ying, Qidi
    Chan, Dick C.
    Pang, Jing
    Croyal, Mikael
    Blanchard, Valentin
    Krempf, Michel
    Watts, Gerald F.
    CLINICAL NUTRITION ESPEN, 2023, 55 : 174 - 177
12345